Characteristics of the Protein datasets in DoSurvive.


Number of Patients tested with protein.

Cancer Types Patients (OS) Patients (DSS) Patients (DFI) Patients (PFI) Gene (OS)
Adrenocortical carcinoma (ACC) 46 46 28 46 220
Bladder Urothelial Carcinoma (BLCA) 343 329 153 344 215
Breast invasive carcinoma (BRCA) 886 868 763 886 222
Cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) 173 170 112 173 219
Cholangiocarcinoma (CHOL) 30 29 21 30 218
Colon adenocarcinoma (COAD) 357 343 142 357 222
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma (DLBC) 33 33 19 33 218
Esophageal carcinoma (ESCA) 126 124 76 126 219
Glioblastoma multiforme (GBM) 237 221 1 237 222
Head and Neck squamous cell carcinoma (HNSC) 365 336 85 356 217
Kidney Chromophobe (KICH) 62 62 27 62 219
Kidney renal clear cell carcinoma (KIRC) 478 468 92 477 232
Kidney renal papillary cell carcinoma (KIRP) 214 212 134 213 220
Brain Lower Grade Glioma (LGG) 428 422 114 428 218
Liver hepatocellular carcinoma (LIHC) 184 177 145 184 219
Lung adenocarcinoma (LUAD) 357 324 203 357 216
Lung squamous cell carcinoma (LUSC) 323 293 210 324 216
Mesothelioma (MESO) 62 46 10 61 219
Ovarian serous cystadenocarcinoma (OV) 421 393 210 421 223
Pancreatic adenocarcinoma (PAAD) 123 116 46 123 220
Pheochromocytoma and Paraganglioma (PCPG) 80 80 72 80 219
Prostate adenocarcinoma (PRAD) 352 351 233 352 218
Rectum adenocarcinoma (READ) 130 124 33 130 222
Sarcoma (SARC) 223 217 126 223 219
Skin Cutaneous Melanoma (SKCM) 342 339 0 343 215
Stomach adenocarcinoma (STAD) 351 328 205 353 218
Testicular Germ Cell Tumors (TGCT) 104 104 79 104 218
Thyroid carcinoma (THCA) 368 362 264 368 216
Thymoma (THYM) 89 89 0 89 218
Uterine Corpus Endometrial Carcinoma (UCEC) 439 438 351 439 222
Uterine Carcinosarcoma (UCS) 48 46 22 48 219
Uveal Melanoma (UVM) 12 12 0 12 219
*OS: Overall survival, DSS: Disease-specific survival, DFI: Disease-free survival, PFI: Progression-free survival